Photo Biomodulation Therapy for Alveolar Osteitis Recovery in Oral Contraceptive Users
NCT ID: NCT06865508
Last Updated: 2025-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2023-11-01
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects
NCT02832180
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
NCT05282940
the Effect of Vitamin B 1 on Menstrual Pattern After Insertion of the IUD.
NCT05971680
Progesterone in Luteal Phase Deficiency
NCT02950948
The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth
NCT02571296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1. Experimental Group: Laser therapy combined with zinc oxide eugenol dressing.
* Laser therapy was administered using a low-level laser device with the following parameters: \[ wavelength 980 nm810, power 500mw, and duration 90 seconds (30second for each 3 sides\].
* Zinc oxide eugenol dressing was applied immediately before the laser therapy.
* The intervention will be performed at \[specified intervals every day 0, day7, day 14, day 30)\]
Laser therapy
Laser therapy was administered using a low-level laser device with the following parameters: \[ wavelength 980 nm810, power 500mw, and duration 90 seconds (30second for each 3 sides\].
zinc oxide eugenol dressing.
zinc oxide eugenol dressing.
control group
zinc oxide eugenol dressing.
zinc oxide eugenol dressing.
zinc oxide eugenol dressing.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laser therapy
Laser therapy was administered using a low-level laser device with the following parameters: \[ wavelength 980 nm810, power 500mw, and duration 90 seconds (30second for each 3 sides\].
zinc oxide eugenol dressing.
zinc oxide eugenol dressing.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Diagnosed with dry socket (alveolar osteitis) based on clinical criteria.
Exclusion Criteria
25 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Badr University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Doaa Saeed Mohamed
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
physical therapy at Badr University in Cairo(BUC)
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BUC-IACUC-231015-38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.